BridgeBio Oncology Therapeutics, Inc. (BBOT)

NASDAQ: BBOT · Real-Time Price · USD

8.74

-0.44 (-4.79%)

At close: Aug 28, 2026, 4:00 PM EDT

8.91

+0.17 (1.95%)

After-hours: Aug 28, 2026, 7:30 PM EDT

BBOT Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Income	-198.96	-145.82	-80.86	-64.77
Net Income	-182.11	-134.04	-74.28	-64.7
Earnings Per Share	-5.84	-4.30	-5756.41	-518.73
EPS Growth	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	344.13	425.46	155.63	0.25
Total Debt	2.51	2.77	-	-
Net Cash (Debt)	341.62	422.69	155.63	0.25
Net Cash Growth	165.72%	171.60%	62152.40%	-
Net Cash Per Share	10.96	13.57	12061.61	2.00

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-151.28	-113.89	-55.03	-52.08
Capital Expenditures	-0.28	-0.61	-0.05	-0.41
Free Cash Flow	-151.56	-114.5	-55.08	-52.49
Free Cash Flow Growth	-	-	-	-

Selected indicators aren't available for this stock.